• Tuesday, January 15, 2019 @ 10:00 am

MedEngine Oy, a company specialized in high-quality medical data science services, and BC Platforms AG, a world leader in genomic data management and analytics, announced a major strategic alliance to create turnkey research solutions for the pharmaceutical and health sectors. The first-of-a-kind partnership brings together BC Platform’s global network of biobanks and MedEngine’s expertise in medical research.

MedEngine provides scientific research, medical communications, and medical advisory services to generate impactful clinical, health economic, and market insights for the pharmaceutical and health tech industries. MedEngine’s internationally recognized projects translate research findings beyond scientific publications into medical practices and activities. By collecting, analyzing, and applying medical data, MedEngine helps its customers design better clinical trials, demonstrate the value of a product to payers, provide tools for treatment optimization, and make better business decisions.

With over 20 years’ experience working in genomics and information technology, BC Platforms has built a global network of biobanks to provide harmonized genomic and clinical cohort data for pharmaceutical and medical research. The company’s high-performing software platform enables flexible data integration, secure analysis, and interpretation of molecular and clinical information.

The new strategic alliance will integrate MedEngine’s research and business knowledge with BC Platforms’ global pool of biobank data and analytics platform. This will strengthen the partner companies’ ability to offer turnkey projects – from study concepts to finalized publications, and all the way to implementation of the data to the benefit of patients.

“We are excited about our new strategic partnership with MedEngine,” says Tero Silvola, CEO of BC Platforms. “We have chosen MedEngine as our strategic partner in service development and production because of MedEngine’s research excellence and deep understanding of customer needs. Together we can develop solutions that help turn data into meaningful knowledge.”

“Both MedEngine and BC Platforms are striving towards strong global growth. Through this partnership we have a unique opportunity to offer top-quality research services that are based on massive datasets of genomic and clinical data from BC Platform’s global network of biobanks,” says Tero Ylisaukko-oja, CEO of MedEngine.

You may also be interested in